Cite
Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation.
MLA
Reddy, Suresh, et al. “Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection after Kidney Transplantation.” Clinical Kidney Journal, vol. 11, no. 3, June 2018, pp. 429–33. EBSCOhost, https://doi.org/10.1093/ckj/sfx112.
APA
Reddy, S., Sharma, R. K., Mehrotra, S., Prasad, N., Gupta, A., Kaul, A., & Bhadauria, D. S. (2018). Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation. Clinical Kidney Journal, 11(3), 429–433. https://doi.org/10.1093/ckj/sfx112
Chicago
Reddy, Suresh, Raj Kumar Sharma, Sonia Mehrotra, Narayan Prasad, Amit Gupta, Anupma Kaul, and Dharmendra Singh Bhadauria. 2018. “Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection after Kidney Transplantation.” Clinical Kidney Journal 11 (3): 429–33. doi:10.1093/ckj/sfx112.